China’s Hengrui posts 89% rise in third-quarter net profit, beating estimates

Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, reported a 20.55 per cent rise in third-quarter revenue to 8.95 billion yuan (US$1.34 billion), beating analyst estimates of 8.55 billion yuan amid stronger innovative drug sales. Net profit reached 2.46 billion

KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.